All stock lists
Unlock the score
Ascendis Pharma A/S (NASDAQ:ASND)
DK · Delayed Price · Currency is USD
Healthcare · Biotechnology
245.15+1.78 (+0.73%)
Market cap
$16.1B
Insider Score
Health Score
Analyst consensus
Listed since
Jan 28, 2015
Website
Insider Score
/ 100
ASND Insider Score
Ascendis Pharma A/S has a live Insider Score.
Scored on 2 qualifying trades from 1 insider in the last 90 days.
ASND Stock Insider Trading Activity
ASND stock’s insider trading shows 9 purchases for an estimated $777.07K and 3 sales on the open market for an estimated $5.51M by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
Scored window · last 90 days2 qualifying buys1 insider$492.65K bought— these are the numbers in the rankings table; the full history below shows every filing (buys, sells and older activity).
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Bodenhoff Mads Other | Option exercise | 3,000 | $110.00 | $330.00K | New | 3,000 | Sep 8, 2026 | — | Form 4 |
| Bodenhoff Mads Other | Sell | 3,000 | $270.19 | $810.57K | 100% | 0 | Sep 8, 2026 | — | Form 4 |
| HOLTUG LARS Director | Sell | 236 | $264.13 | $62.33K | 5.6% | 4,000 | Sep 2, 2026 | — | Form 4 |
| BIENAIME JEAN JACQUES Director | Buy | 1,100 | $245.85 | $270.44K | 122% | 2,000 | Aug 14, 2026 | CStake Doubler | Form 4 |
| BIENAIME JEAN JACQUES Director | Buy | 900 | $246.91 | $222.22K | 45.0% | 2,900 | Aug 14, 2026 | F | Form 4 |
| SMITH SCOTT THOMAS CFO | Buy | 100 | $219.00 | $21.90K | 2.3% | 4,367 | Jun 2, 2026 | CCFO Buy | Form 4 |
| BIENAIME JEAN JACQUES Director | Buy | 200 | $223.76 | $44.75K | 50.0% | 600 | May 29, 2026 | D | Form 4 |
| BIENAIME JEAN JACQUES Director | Buy | 200 | $222.30 | $44.46K | 33.3% | 800 | May 29, 2026 | F | Form 4 |
| BIENAIME JEAN JACQUES Director | Buy | 100 | $223.50 | $22.35K | 12.5% | 900 | May 29, 2026 | F | Form 4 |
| SMITH SCOTT THOMAS CFO | Buy | 250 | $223.32 | $55.83K | 6.2% | 4,267 | May 29, 2026 | CFirst BuyCFO Buy | Form 4 |
| BIENAIME JEAN JACQUES Director | Buy | 200 | $236.24 | $47.25K | New | 200 | May 26, 2026 | CFirst Buy | Form 4 |
| BIENAIME JEAN JACQUES Director | Buy | 200 | $239.37 | $47.87K | 100% | 400 | May 26, 2026 | CFirst BuyStake Doubler | Form 4 |
| JENSEN FLEMMING STEEN Other | Sell | 19,460 | $238.49 | $4.64M | 100% | 0 | May 11, 2026 | — | Form 4 |
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
- Buy (P) — Open-market or private purchase
- Sell (S) — Open-market or private sale
- Option exercise (M) — Exercise or conversion of an exempt derivative
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.